CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-16 | Acosta Andrea GVP, Chief Accounting Officer | Shares withheld for taxes | −285 | $78.84 | $22K | 18,122 |
| 2021-06-29 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −576 | $83.46 | $48K | 30,781 |
| 2021-06-21 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +1,000 | $37.46 | $37K | 304,839 |
| 2021-06-21 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −1,000 | 138,000 | ||
| 2021-05-25 | Slamon Dennis Director | Grant or award | +5,120 | 28,035 | ||
| 2021-05-25 | PYOTT DAVID E I Director | Grant or award | +5,120 | 35,860 | ||
| 2021-05-25 | MEIER RICHARD A Director | Grant or award | +5,120 | 99,392 | ||
| 2021-05-25 | LAWLIS V BRYAN Director | Grant or award | +5,120 | 23,970 | ||
| 2021-05-25 | HOMBACH ROBERT J. Director | Grant or award | +5,120 | 21,330 | ||
| 2021-05-25 | Ho Maykin Director | Grant or award | +5,120 | 7,470 | ||
| 2021-05-25 | HERON ELAINE J Director | Grant or award | +5,120 | 72,088 | ||
| 2021-05-25 | Dere Willard H Director | Grant or award | +5,120 | 18,410 | ||
| 2021-05-25 | ANDERSON ELIZABETH M Director | Grant or award | +5,120 | 13,910 | ||
| 2021-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +8,513 | $26.49 | $226K | 312,352 |
| 2021-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −8,513 | $77.29 | $658K | 303,839 |
| 2021-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −8,513 | 0 | ||
| 2021-05-07 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +6,709 | $28.23 | $189K | 38,066 |
| 2021-05-07 | Mueller Brian EVP, Chief Financial Officer | Sale | −6,709 | $79.50 | $533K | 31,357 |
| 2021-05-07 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −6,709 | 0 | ||
| 2021-05-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +25,000 | $26.49 | $662K | 328,839 |
Page 28 of 36 · 707 trades